Creative Medical Technology Holdings (CELZ) Price to Book (2016 - 2026)

Creative Medical Technology Holdings (CELZ) has reported Price to Book for 11 consecutive years, with 0.22 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 56.96% year-over-year to 0.22 in Q2 2026; TTM through Jun 2026 was 0.22, a 56.96% decrease from a year earlier, with the FY2025 full-year figure at 0.36, down 28.49% from the prior year.
• Price to Book was 0.22 for Q2 2026 at Creative Medical Technology Holdings, down from 0.45 in the prior quarter.
• Over five years, Price to Book peaked at 3.17 in Q4 2023 and troughed at 0.22 in Q2 2026.
• A 5-year average of 0.75 and a median of 0.48 in 2023 frame the typical range for Price to Book.
• Across the five-year window, Price to Book jumped 1105.68% in 2023 and tumbled 84.7% in 2024, its largest moves.
• Over 5 years, Price to Book stood at 0.26 in 2022, then jumped by 1105.68% to 3.17 in 2023, then slumped by 84.7% to 0.48 in 2024, then decreased by 28.49% to 0.35 in 2025, then slumped by 35.86% to 0.22 in 2026.
• The last three Price to Book figures came in at 0.22 (Q2 2026), 0.45 (Q1 2026), and 0.35 (Q4 2025), per Business Quant data.